SHAREHOLDERS’ DEFICIT (Details Narrative)
|
|
|
|
|
1 Months Ended |
3 Months Ended |
6 Months Ended |
12 Months Ended |
|
|
|
|
|
Jan. 21, 2025
USD ($)
shares
|
Jan. 03, 2025 |
Feb. 29, 2024 |
May 18, 2023
$ / shares
shares
|
Feb. 28, 2025
USD ($)
shares
|
May 31, 2023
shares
|
Jun. 30, 2025
USD ($)
$ / shares
shares
|
Mar. 31, 2025
shares
|
Jun. 30, 2024
USD ($)
|
Jun. 30, 2025
USD ($)
Integer
$ / shares
shares
|
Jun. 30, 2024
USD ($)
|
Dec. 31, 2024
USD ($)
Integer
$ / shares
shares
|
Dec. 31, 2023
USD ($)
$ / shares
shares
|
May 13, 2025
shares
|
May 22, 2024
$ / shares
|
Apr. 16, 2024
$ / shares
shares
|
Mar. 01, 2024
$ / shares
shares
|
Oct. 31, 2023
$ / shares
shares
|
Class of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Preference shares, shares authorized |
|
|
|
|
|
|
|
|
|
|
|
5,000,000
|
5,000,000
|
|
|
|
|
|
Preference shares, par value | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
$ 0.0001
|
$ 0.0001
|
|
|
|
|
|
Preference shares, shares outstanding |
|
|
|
|
|
|
|
|
|
|
|
0
|
0
|
|
|
|
|
|
Preference shares, shares issued |
|
|
|
|
|
|
|
|
|
|
|
0
|
0
|
|
|
|
|
|
Shares issued, price per share | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
$ 11.43
|
|
|
|
|
|
|
Public warrant exercisable term |
|
|
|
|
|
|
|
|
|
|
|
6 months
|
|
|
|
|
|
|
General and administrative expenses | $ |
|
|
|
|
|
|
|
|
|
|
|
$ 3,088,671
|
$ 1,340,168
|
|
|
|
|
|
Public Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Redemption price per public warrant | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
$ 0.01
|
|
|
|
|
|
|
Redemption period |
|
|
|
|
|
|
|
|
|
|
|
30 days
|
|
|
|
|
|
|
Warrant redemption condition minimum share price | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
$ 18.00
|
|
|
|
|
|
|
Threshold trading days for redemption of public warrants |
|
|
|
|
|
|
|
|
|
|
|
20 days
|
|
|
|
|
|
|
Threshold consecutive trading days for redemption of public warrants | Integer |
|
|
|
|
|
|
|
|
|
|
|
30
|
|
|
|
|
|
|
Common Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares issued, price per share | $ / shares |
|
|
|
$ 10.55
|
|
|
|
|
|
|
|
|
|
|
$ 11.24
|
|
|
|
Aspire Biopharma Inc [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock, shares authorized |
|
|
|
|
|
750,000,000
|
|
|
|
|
|
750,000,000
|
750,000,000
|
|
|
|
|
|
Common stock, par value | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
$ 0.00005
|
$ 0.00005
|
|
|
|
|
|
Common stock, shares outstanding |
|
|
|
|
|
|
|
|
|
|
|
440,000,000
|
440,000,000
|
|
|
|
|
|
Stockholders equity note stock split conversion ratio |
|
|
|
|
|
20:1
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of warrants issued |
|
|
|
|
|
|
|
|
|
|
|
44,000,000
|
7,500,000
|
|
|
|
|
|
Exercise price of warrants | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
$ 0.40
|
$ 0.02
|
|
|
|
|
|
Warrants outstanding | $ |
|
|
|
|
|
|
|
|
|
|
|
$ 91,500,000
|
$ 47,500,000
|
|
|
|
|
|
General and administrative expenses | $ |
|
|
|
|
|
|
|
|
|
|
|
$ 940,421
|
$ 246,895
|
|
|
|
|
|
Aspire Biopharma Inc [Member] | Common Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock, shares authorized |
|
|
|
|
|
|
|
|
|
|
|
750,000,000
|
|
|
|
|
|
|
Common stock, par value | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
$ 0.001
|
|
|
|
|
|
|
Common stock, shares outstanding |
|
|
|
|
|
|
|
|
|
|
|
440,000,000
|
|
|
|
|
|
|
Parent Company [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Preference shares, shares authorized |
|
|
|
|
|
|
10,000,000
|
|
|
10,000,000
|
|
10,000,000
|
|
|
|
|
|
|
Preference shares, par value | $ / shares |
|
|
|
|
|
|
$ 0.0001
|
|
|
$ 0.0001
|
|
$ 0.0001
|
|
|
|
|
|
|
Preference shares, shares outstanding |
|
|
|
|
|
|
0
|
|
|
0
|
|
0
|
|
|
|
|
|
|
Common stock, shares authorized |
|
|
|
|
|
|
490,000,000
|
|
|
490,000,000
|
|
490,000,000
|
|
|
|
|
|
|
Common stock, par value | $ / shares |
|
|
|
|
|
|
$ 0.0001
|
|
|
$ 0.0001
|
|
$ 0.0001
|
|
|
|
|
|
|
Common stock, shares outstanding |
|
|
|
|
|
|
49,525,970
|
|
|
49,525,970
|
|
27,601,767
|
|
2,929,000
|
|
|
|
|
Preference shares, shares issued |
|
|
|
|
|
|
0
|
|
|
0
|
|
0
|
|
|
|
|
|
|
Number of warrants issued |
|
|
|
|
|
|
|
|
|
|
|
44,000,000
|
7,500,000
|
|
|
|
|
|
Exercise price of warrants | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
$ 0.40
|
$ 0.13
|
|
|
|
|
|
Warrants outstanding | $ |
$ 91,500,000
|
|
|
|
|
|
|
|
|
|
|
$ 91,500,000
|
|
|
|
|
|
|
Common stock, shares issued |
|
|
|
|
|
|
49,525,970
|
|
|
49,525,970
|
|
27,601,767
|
|
|
|
|
|
|
General and administrative expenses | $ |
|
|
|
|
|
|
$ 395,692
|
|
$ 86,423
|
$ 15,469,240
|
$ 219,227
|
|
|
|
|
|
|
|
Parent Company [Member] | Corporate Advisory Agreement [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares outstanding percentage |
|
4.75%
|
6.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Business combination shares issued |
|
|
|
|
1,662,500
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Business combination shares |
|
|
|
|
35,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
General and administrative expenses | $ |
|
|
|
|
$ 14,131,250
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Market price discount percentage |
|
|
|
|
15.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Parent Company [Member] | Public Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sale of private placement warrants |
|
|
|
|
|
|
14,374,969
|
|
|
14,374,969
|
|
|
|
|
|
|
|
|
Public warrant exercisable term |
|
|
|
|
|
|
30 days
|
|
|
30 days
|
|
|
|
|
|
|
|
|
Redemption price per public warrant | $ / shares |
|
|
|
|
|
|
|
|
|
$ 0.01
|
|
|
|
|
|
|
|
|
Redemption period |
|
|
|
|
|
|
|
|
|
30 days
|
|
|
|
|
|
|
|
|
Warrant redemption condition minimum share price | $ / shares |
|
|
|
|
|
|
|
|
|
$ 18.00
|
|
|
|
|
|
|
|
|
Threshold trading days for redemption of public warrants |
|
|
|
|
|
|
|
|
|
20 days
|
|
|
|
|
|
|
|
|
Threshold consecutive trading days for redemption of public warrants | Integer |
|
|
|
|
|
|
|
|
|
30
|
|
|
|
|
|
|
|
|
Parent Company [Member] | Private Placement Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sale of private placement warrants |
|
|
|
|
|
|
9,763,333
|
|
|
9,763,333
|
|
|
|
|
|
|
|
|
Parent Company [Member] | Common Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock conversion |
91,500,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common Class A [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock, shares authorized |
|
|
|
|
|
|
|
|
|
|
|
300,000,000
|
300,000,000
|
|
|
|
|
|
Common stock, par value | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
$ 0.0001
|
$ 0.0001
|
|
|
|
|
|
Common stock, shares outstanding |
|
|
|
|
|
|
|
|
|
|
|
7,187,500
|
7,187,500
|
|
|
|
|
|
Common stock, shares issued |
|
|
|
|
|
|
|
|
|
|
|
7,187,500
|
7,187,500
|
|
|
|
|
|
Common Class A [Member] | Parent Company [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock, shares authorized |
|
|
|
|
|
|
490,000,000
|
|
|
490,000,000
|
|
490,000,000
|
|
|
|
|
|
|
Common stock, par value | $ / shares |
|
|
|
|
|
|
$ 0.0001
|
|
|
$ 0.0001
|
|
$ 0.0001
|
|
|
|
|
|
|
Common stock, shares outstanding |
|
|
|
|
|
|
49,525,970
|
|
|
49,525,970
|
|
27,601,767
|
|
|
|
|
|
|
Common stock, shares issued |
|
|
|
|
|
|
49,525,970
|
|
|
49,525,970
|
|
27,601,767
|
|
|
|
|
|
|
Class A common stock conversion |
5,735,717
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common Class A [Member] | Parent Company [Member] | Public Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise price of warrants | $ / shares |
|
|
|
|
|
|
$ 11.50
|
|
|
$ 11.50
|
|
|
|
|
|
|
|
|
Common Class A [Member] | Parent Company [Member] | Private Placement Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise price of warrants | $ / shares |
|
|
|
|
|
|
$ 11.50
|
|
|
$ 11.50
|
|
|
|
|
|
|
|
|
Common Class A [Member] | Parent Company [Member] | Common Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Business combination shares issued |
|
|
|
|
|
|
|
1,662,500
|
|
|
|
|
|
|
|
|
|
|
Business combination shares |
|
|
|
|
|
|
|
7,257,513
|
|
|
|
|
|
|
|
|
|
|
Common Class A Subject to Redemption [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Temporary Equity, Shares Outstanding |
|
|
|
|
|
|
|
|
|
|
|
577,644
|
1,803,729
|
|
|
|
|
|
Ordinary shares subject to possible redemption, shares issued |
|
|
|
|
|
|
|
|
|
|
|
577,644
|
1,803,729
|
|
|
|
|
|
Common Class B [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock, shares authorized |
|
|
|
|
|
|
|
|
|
|
|
50,000,000
|
50,000,000
|
|
|
|
|
|
Common stock, par value | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
$ 0.0001
|
$ 0.0001
|
|
|
|
|
|
Common stock, shares outstanding |
|
|
|
|
|
|
|
|
|
|
|
0
|
0
|
|
|
|
|
|
Ratio to be applied to the stock in the conversion |
|
|
|
|
|
|
|
|
|
|
|
20.00%
|
|
|
|
|
|
|
Common stock, shares issued |
|
|
|
|
|
|
|
|
|
|
|
0
|
0
|
|
|
|
|
|
Class A common stock conversion |
|
|
|
7,187,500
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Series A Preferred Stock [Member] | Aspire Biopharma Inc [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Preference shares, shares authorized |
|
|
|
|
|
|
|
|
|
|
|
25,000,000
|
25,000,000
|
|
|
|
|
25,000,000
|
Preference shares, par value | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
$ 0.0001
|
$ 0.0001
|
|
|
|
|
$ 0.0001
|
Preference shares, shares outstanding |
|
|
|
|
|
|
|
|
|
|
|
322,059
|
0
|
|
|
|
|
|
Preference shares, shares issued |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
35,702
|
286,357
|
|
Shares issued, price per share | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.80
|
$ 0.80
|
|